Stay updated with breaking news from Pharma Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Love Pharma adding to its addiction treatment portfolio with transdermal IP acquisition for opioid antagonist drug NaltrexoneNaltrexone primarily used to treat alcohol and or opioid use disorder and is
Starton Therapeutics is a leading clinical stage Biotechnology Company based in New Jersey led by CEO and Chairman, Mr. Pedro Lichtinger, Former President of Global Primary Care & President of Europe at
Love Pharma President, Mr. Zach Stadnyk, delivers comprehensive report on the Company's holdings and growth strategyBuilding upon the Company's major research initiative, led by an addiction research leader
Press release content from Accesswire. The AP news staff was not involved in its creation.
On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances received fu...